Skip to content

Observational study on the effect of climatotherapy on quality of life, anxiety, depression, perceived stigmatization in Swedish individuals with type 1 (early onset) psoriasis.

Observational study on the effect of climatotherapy on quality of life, anxiety, depression, perceived stigmatization in Swedish individuals with type 1 (early onset) psoriasis. - PSOSOL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00014916
Enrollment
45
Registered
2018-07-10
Start date
2018-06-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L40

Interventions

Group 1: Swedish psoriasis patients ages 15-35 attending climate therapy complete questionnaires/surveys at the start of, at the end of and 3 months after a 3 week climatotherapy trip. This is done du

Sponsors

Region Skåne
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 35 Years

Inclusion criteria

Inclusion criteria: Psoriasis patients attending climatotherapy trips organized by Swedish patients organization for young people with psoriasis "Ung med psoriasis".

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

MeasureTime frame
The secondary outcome is long time follow up assessing stress, anxiety, depressive symptoms, perceived stigmatization, itch and quality of life 3 months after climatotherapy in young people with psoriasis. This is assessed by comparing the response of surveys completed at the beginning of, the end of the 3 weeks climatotherapy trip with responses of a survey performed 3 months after.

Primary

MeasureTime frame
The primary goal is to assess the short term effects of climatotherapy on stress, anxiety, depressive symptoms, perceived stigmatization, itch and quality of life in young people with psoriasis. This is assessed by comparing responses of surveys completed at the beginning and the end of the climatotherapy trip.

Countries

Sweden

Contacts

Public ContactAlbert Duvetorp

IKE Linköpings UniversitetSkåne University Hospital Malmö

albert.duvetorp@skane.se+4640331000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026